We have previously shown that astrocytes, present in demyelinating MS lesions, do express TG2 and can interact with ECM proteins, including fibronectin (van Strien et al., 2011b,c; Espitia Pinzón et al., 2017a,b). Here, TGM2 is linked to myeloid sarcoma.